Pronađeno: 1-10 / 24 radova

Autori: Ruzic Dusan

>> Prikaži sve rezultate

Naslov Pharmacological manipulation of liver fibrosis progression using novel HDAC6 inhibitors (Article)
Autori Borrello Maria Teresa  Ruzic Dusan  ...  Radovic Branko  ...  Petkovic Milos R  Nikolic Katarina M  ...  (broj koautora 26) 
Info FEBS JOURNAL, (2025), vol. 292 br. 13, str. 3397-3411
Projekat Ministry of Science, Technological Development and Innovation, Republic of Serbia [MR/K10019494/1, MR/R023026/1]; UK Medical Research Council [NIHR203309]; National Institute for Health Research (NIHR) Newcastle Biomedical Research Centre (BRC) [MR/X036766/1]; Medical Research Council [C18342/A23390, DRCRPG-Nov22/100007]; Cancer Research UK [PGL22/100014]; Rosetrees Trust; Intensive Industrial Innovation Programme: European Regional Development Fund PhD studentship [451-03-65/2024-03/200161]; Ministry of Science, Technological Development, and Innovation, Republic of Serbia
Ispravka ISI/Web of Science   Članak   Elečas   Rang časopisa   Citati: ISI/Web of Science  
Naslov A computational framework for the design and development of ERK2 and multi-target ERK2/HDAC inhibitors (Article)
Autori Cebzan Alen  Ruzic Dusan  Djokovic Nemanja  Stankovic Branislav D  Nikolic Katarina M 
Info COMPUTATIONAL BIOLOGY AND CHEMISTRY, (2025), vol. 119 br. , str. -
Projekat Ministry of Science, Technological Development and Innovation, Republic of Serbia; University of Belgrade-Faculty of Pharmacy [451-03-136/2025-03/200161, 451-03-137/2025-03/200161]; Vinca Institute of Nuclear Sciences; Ministry of Science, Technological Development and Innovation of the Republic of Serbia [451-03-136/2025-03/200017]; Faculty of Physics
Ispravka ISI/Web of Science   Članak   Elečas   Rang časopisa  
Naslov The histone deacetylase inhibitor Scriptaid targets G-quadruplexes (Article)
Autori Sanchez Martin Victoria  Ruzic Dusan  Tello Lopez Maria J  Ortiz Morales Andrea  Murciano Calles Javier  Soriano Miguel  Nikolic Katarina M  Garcia Salcedo Jose Antonio 
Info OPEN BIOLOGY, (2025), vol. 15 br. 2, str. -
Projekat Ministry of Science and Innovation of Spain (Instituto de Salud Carlos III (ISCIII) - European Union) [PI21/00497, PID2020-120481RB-I00/AEI/10.13039/501100011033]; local government Junta de Andalucia through PAIDI research groups [BIO-344]; Ministry of Science, Technological Development and Innovation of the Republic of Serbia (University of Belgrade-Faculty of Pharmacy) [451-03-65/2024-03/200161]; Government of Spain [FPU16/05822]; University of Almeria [CPRE2023-069]
Ispravka ISI/Web of Science   Članak   Elečas   Rang časopisa  
Naslov Pioneering first-in-class HDAC-ROCK inhibitors as potential multitarget anticancer agents (Article)
Autori Beljkas Milan  Ruzic Dusan  Djuric Ana  Vuletic Ana M  Tchiehe Guilaine Nchugoua  Jallet Corinne  Cadet Daniel Veronique  Arimondo Paola B  Santibanez Juan Francisco  Srdic-Rajic Tatjana V  Nikolic Katarina M  Oljacic Slavica V  Petkovic Milos R 
Info FUTURE MEDICINAL CHEMISTRY, (2025), vol. 17 br. 4, str. 393-407
Projekat Ministry of Science, Technological Development and Innovation, Republic of Serbia; University of Belgrade-Faculty of Pharmacy [451- 03-65/2024-03/200161, 451-03-66/2024-03/200161]; Ministry of Science, Technological Development and Innovation, Republic of Serbia; University of Belgrade-Institute for Medical Research [451-03-66/2024-03/200015]; Ministry of Science, Technological Development and Innovation, Republic of Serbia; Institute for Oncology and Radiology of Serbia [451-03-66/2024-03/200043]
Ispravka ISI/Web of Science   Članak   Elečas   Rang časopisa  
Naslov Pioneering first-in-class HDAC-ROCK inhibitors as potential multitarget anticancer agents (Article; Early Access)
Autori Beljkas Milan  Ruzic Dusan  Djuric Ana  Vuletic Ana M  Tchiehe Guilaine Nchugoua  Jallet Corinne  Cadet Daniel Veronique  Arimondo Paola B  Santibanez Juan Francisco  Srdic-Rajic Tatjana V  Nikolic Katarina M  Oljacic Slavica V  Petkovic Milos R 
Info FUTURE MEDICINAL CHEMISTRY, (2025), vol. br. , str. -
Projekat Ministry of Science, Technological Development and Innovation, Republic of Serbia, through Grant Agreement with University of Belgrade-Faculty of Pharmacy [451- 03-65/2024-03/200161, 451-03-66/2024-03/200161]; Ministry of Science, Technological Development and Innovation, Republic of Serbia, through Grant Agreement with University of Belgrade-Institute for Medical Research [451-03-66/2024-03/200015]; Ministry of Science, Technological Development and Innovation, Republic of Serbia, through Grant Agreement with Institute for Oncology and Radiology of Serbia [451-03-66/2024-03/200043]
Ispravka ISI/Web of Science   Članak   Elečas   Rang časopisa   Citati:
Naslov Targeting Histone Deacetylases 6 in Dual-Target Therapy of Cancer (Review)
Autori Beljkas Milan  Ilic Aleksandra  Cebzan Alen  Radovic Branko  Djokovic Nemanja  Ruzic Dusan  Nikolic Katarina M  Oljacic Slavica V 
Info PHARMACEUTICS, (2023), vol. 15 br. 11, str. -
Projekat Ministry of Science, Technological Development and Innovation, Republic of Serbia
Ispravka ISI/Web of Science   Članak   Elečas   Rang časopisa  
Naslov Correlating Basal Gene Expression across Chemical Sensitivity Data to Screen for Novel Synergistic Interactors of HDAC Inhibitors in Pancreatic Carcinoma (Article)
Autori Djokovic Nemanja  Djuric Ana  Ruzic Dusan  Srdic-Rajic Tatjana V  Nikolic Katarina M 
Info PHARMACEUTICALS, (2023), vol. 16 br. 2, str. -
Projekat Ministry of Science, Technological Development and Innovation, Republic of Serbia; University of Belgrade-Faculty of Pharmacy [451-03-47/2023-01/200161]
Ispravka ISI/Web of Science   Članak   Elečas   Rang časopisa  
Naslov Discovery of 1-Benzhydryl-Piperazine-Based HDAC Inhibitors with Anti-Breast Cancer Activity: Synthesis, Molecular Modeling, In Vitro and In Vivo Biological Evaluation (Article)
Autori Ruzic Dusan  Ellinger Bernhard  Djokovic Nemanja  Santibanez Juan Francisco  Gul Sheraz  Beljkas Milan  Djuric Ana  Ganesan Arasu  Pavic Aleksandar B  Srdic-Rajic Tatjana V  Petkovic Milos R  Nikolic Katarina M 
Info PHARMACEUTICS, (2022), vol. 14 br. 12, str. -
Projekat Ministry of Education, Science and Technological Development, Republic of Serbia with University of Belgrade-Faculty of Pharmacy [451-03-68/2022-14/200161]; Ministry of Education, Science, and the Technological Development of the Republic of Serbia [ON171017]
Ispravka ISI/Web of Science   Članak   Elečas   Rang časopisa   Citati: ISI/Web of Science  
Naslov Dual LSD1 and HDAC6 Inhibition Induces Doxorubicin Sensitivity in Acute Myeloid Leukemia Cells (Article)
Autori Bulut Ipek  Lee Adam  Cevatemre Buse  Ruzic Dusan  Belle Roman  Kawamura Akane  Gul Sheraz  Nikolic Katarina M  Ganesan A  Acilan Ceyda 
Info CANCERS, (2022), vol. 14 br. 23, str. -
Projekat Koc University School of Medicine (KU-SOM budget) [255021011]; Koc University Research Center for Translational Medicine (KUTTAM); Turkish Ministry of Health (TUSEB) [4012]; UKRI Biotechnology and Biological Sciences Research Council, Norwich Research Park, Biosciences Doctoral Training Partnership [BB/M011216/1]; Ministry of Education, Science and Technological Development, Republic of Serbia [451-03-9/2021-14/200161]; Cancer Research UK [C8717/A18245]; European Research Council (ERC) under the European Union [679479]; EU COSTAction CM1406 Epigenetic Chemical Biology
Ispravka ISI/Web of Science   Članak   Elečas   Rang časopisa   Citati: ISI/Web of Science  
Naslov Design of Dual COX-2 and 5-LOX Inhibitors with Iron-Chelating Properties Using Structure-Based and Ligand-Based Methods (Article)
Autori Boskovic Jelena  Ruzic Dusan  Cudina Olivera A  Nikolic Katarina M  Dobricic Vladimir D 
Info LETTERS IN DRUG DESIGN & DISCOVERY, (2022), vol. 19 br. 4, str. 279-292
Projekat Ministry of Education, Science and Technological Development, Republic of Serbia; University of Belgrade-Faculty of Pharmacy [451-03-9/2021-14/200161]
Ispravka ISI/Web of Science   Članak   Elečas   Rang časopisa   Citati: ISI/Web of Science   Scopus  
Ispis zapisa u formatu:TXT | BibTeX